Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model.

Plant-derived phytoestrogens have bone protective effects, but the molecular mechanism behind these effects remains unclear. This study is aimed at fully characterizing the fracture healing process of formononetin, and investigating the mechanism underlying angiogenesis in calluses of a rat fracture model. Femoral fractures were produced in 2-month-old Sprague-Dawley rats. A 20 microg/kg or 200 microg/kg dose of formononetin was orally administrated once a day during the healing period of 21 days. The results showed that in the early stage of chondrogenesis (days 3), formononetin significantly increased the number of vessels, and expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2/flk-1) compared with control. However, the larger dose of formononetin had no significant difference on expression of VEGF and VEGFR-2/Flk-1 compared with that of the smaller dose of formononetin. After 7 days of administration, formononetin markedly induced differentiation of mesenchymal stem cells in the fracture site. After 14 days, gene expression of mesenchymal progenitors such as alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OPN) and collagen type I (Col I), indicating osteogenic differentiation, was markedly stimulated by formononetin compared with control. These results suggest that formononetin promotes early fracture healing through angiogenesis activation in the early stage of fracture repair, and osteogenesis acceleration in the later stages, and thus may be beneficial for fracture healing.

[1]  A. Rabie,et al.  Effect of naringin collagen graft on bone formation. , 2006, Biomaterials.

[2]  A. Husband,et al.  Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[4]  Ping Li,et al.  Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats. , 2006, The American journal of Chinese medicine.

[5]  D. Graves,et al.  Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Yunchao Su,et al.  Calpain‐2 regulation of VEGF‐mediated angiogenesis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  W. Puhl,et al.  Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. , 2002, Bone.

[8]  Jui-Sheng Sun,et al.  Isoflavones prevent bone loss following ovariectomy in young adult rats , 2008, Journal of Orthopaedic Surgery and Research.

[9]  Y. Ishimi,et al.  Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. , 2000, Biochemical and biophysical research communications.

[10]  P. Nestel,et al.  An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. , 2007, Atherosclerosis.

[11]  E. Kennelly,et al.  Phytoestrogens: a review of the present state of research , 2003, Phytotherapy research : PTR.

[12]  H. Frost,et al.  The biology of fracture healing. An overview for clinicians. Part I. , 1989, Clinical orthopaedics and related research.

[13]  H. Redmond,et al.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Christoph Dehio,et al.  VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. , 2005, Biochemical and biophysical research communications.

[15]  M. Danilenko,et al.  Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells , 2007, Breast Cancer Research and Treatment.

[16]  A. Jungbauer,et al.  Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy? , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  R. Carano,et al.  Angiogenesis and bone repair. , 2003, Drug discovery today.

[18]  T. Hautala,et al.  Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro , 2006, BMC musculoskeletal disorders.

[19]  U. Sommer,et al.  Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing* , 2007, Journal of Biological Chemistry.

[20]  G. Schmidmaier,et al.  Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat , 2002, Cell and Tissue Research.

[21]  L. Qin,et al.  Epimedium‐Derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24‐Month Randomized, Double‐Blind and Placebo‐Controlled Trial , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  Yiwei Li,et al.  Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein , 2004, Cancer and Metastasis Reviews.

[23]  K. Cashman,et al.  Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. , 2003, Nutrition reviews.

[24]  M. Perrot-Applanat,et al.  Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. , 2008, The Journal of endocrinology.

[25]  A. Rabie,et al.  Effect of naringin on bone cells , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  Christina Eckhardt,et al.  Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  M. Lafage-Proust,et al.  Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation. , 2008, Bone.

[28]  M. Birch,et al.  Vascular endothelial growth factor receptors in osteoclast differentiation and function. , 2005, Biochemical and biophysical research communications.

[29]  M. Kumegawa,et al.  Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts , 2000, FEBS letters.

[30]  Christopher J. Robinson,et al.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.

[31]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[32]  P. Chilibeck,et al.  Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? , 2007, Nutrition reviews.

[33]  David J Mooney,et al.  VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[35]  E H Schemitsch,et al.  Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.

[36]  M. Bostrom,et al.  Synthetic bone scaffolds and fracture repair. , 2007, Injury.

[37]  N. Ferrara.  Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.

[38]  George K Stylios,et al.  Present status and future potential of enhancing bone healing using nanotechnology. , 2007, Injury.

[39]  M. Itoman,et al.  Low-intensity pulsed ultrasound treatment for postoperative delayed union or nonunion of long bone fractures , 2007, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[40]  Y. Harada,et al.  Low‐Intensity Pulsed Ultrasound Accelerates Rat Femoral Fracture Healing by Acting on the Various Cellular Reactions in the Fracture Callus , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  B. Kıvçak,et al.  The effects of phytoestrogens on fracture healing: experimental research in New Zealand white rabbits. , 2008, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES.

[42]  M. Dowsett,et al.  The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. , 2004, The American journal of clinical nutrition.

[43]  F. Branca,et al.  Health effects of phytoestrogens. , 2005, Forum of nutrition.